They can modulate hypoxia-inducible factors (HIF), e.g., suppression of HIF-1α and activation of HIF-2α, to improve oxidative stress in the kidney, but their renal protective and glucose-lowering effects seem less satisfactory in advanced DN patients [44, 45]. Here, EPAS1 is linked to liver dysplastic nodule.